Uncategorised - European Medical Journal

10 Sep 2025

Avelumab 1L Maintenance in aUC: Insights from 5000+ Real-World Patients

Urothelial carcinoma (UC), a prevalent cancer affecting the urinary tract, often progresses to an advanced, terminal…

Informed Formula Choices for Infants with CMA

This symposium review article discusses the latest European guidelines for the diagnosis and treatment of cow’s milk allergy in young…

10 Sep 2025

Alzheimer’s Diagnosis Dilemma: How Do You Confirm the Presence of Amyloid?

When evaluating patients with cognitive impairment, early confirmation of amyloid can change the course of care, yet the tools to do so…

Managing Ocular Side Effects of ADCs in Gynecologic Cancer

Ocular toxicities are an emerging challenge in the management of gynecologic cancers treated with antibody drug conjugates, with new research outlining prevention and care strategies to safeguard patient outcomes.

Schizophrenia Diagnosis Reframed in ICD-11 Criteria

The transition from ICD-10 to ICD-11 has introduced substantial revisions in the classification of schizophrenia and catatonia, reshaping diagnostic approaches for clinicians worldwide.

WCLC 2025: DLL3 Therapy Shows Promise in Relapsed SCLC

A first-in-human trial has demonstrated encouraging clinical activity and manageable safety for the DLL3-targeted antibody-drug conjugate SHR-4849 in patients with relapsed small cell lung cancer (SCLC).

Lilly's TuneLab to share AI models with small biotechs

Lilly has launched TuneLab, giving biotech companies access to AI-powered drug discovery models based on over £1bn in research investment.

Corrigendum: Diabetic Ketoacidosis in Pregnancy: An Overview of Pathophysiology, Management, and Pregnancy Outcomes

Central Lung Tumour Location Tied to Worse Outcomes Post-Surgery

Central tumour location linked to worse survival in lung cancer, suggesting need for closer post-operation monitoring.

Sara Tolaney

Onc Now: Episode 25: From Trials to Treatment in Breast Cancer Care

Sara Tolaney shares insights on breast cancer care, including her research on CDK4/6 inhibitors and exploring ways to de-escalate treatment.